InflaRx Statistics
Total Valuation
InflaRx has a market cap or net worth of $112.89 million. The enterprise value is $62.54 million.
Important Dates
The last earnings date was Wednesday, May 7, 2025, before market open.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
InflaRx has 67.60 million shares outstanding. The number of shares has increased by 2.67% in one year.
| Current Share Class | 67.60M |
| Shares Outstanding | 67.60M |
| Shares Change (YoY) | +2.67% |
| Shares Change (QoQ) | +8.34% |
| Owned by Insiders (%) | 6.39% |
| Owned by Institutions (%) | 10.79% |
| Float | 57.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 805.00 |
| Forward PS | 161.77 |
| PB Ratio | 1.39 |
| P/TBV Ratio | 1.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 445.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.28, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.28 |
| Quick Ratio | 3.02 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2,661.73 |
Financial Efficiency
Return on equity (ROE) is -54.13% and return on invested capital (ROIC) is -40.06%.
| Return on Equity (ROE) | -54.13% |
| Return on Assets (ROA) | -34.47% |
| Return on Invested Capital (ROIC) | -40.06% |
| Return on Capital Employed (ROCE) | -75.60% |
| Revenue Per Employee | $1,895 |
| Profits Per Employee | -$653,200 |
| Employee Count | 74 |
| Asset Turnover | 0.00 |
| Inventory Turnover | 0.35 |
Taxes
In the past 12 months, InflaRx has paid $5,639 in taxes.
| Income Tax | 5,639 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +41.53% in the last 52 weeks. The beta is 1.59, so InflaRx's price volatility has been higher than the market average.
| Beta (5Y) | 1.59 |
| 52-Week Price Change | +41.53% |
| 50-Day Moving Average | 1.25 |
| 200-Day Moving Average | 1.72 |
| Relative Strength Index (RSI) | 61.81 |
| Average Volume (20 Days) | 254,287 |
Short Selling Information
| Short Interest | 1.13M |
| Short Previous Month | 924,154 |
| Short % of Shares Out | 1.47% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.42 |
Income Statement
In the last 12 months, InflaRx had revenue of $140,242 and -$48.34 million in losses. Loss per share was -$0.81.
| Revenue | 140,242 |
| Gross Profit | -3.22M |
| Operating Income | -57.85M |
| Pretax Income | -51.25M |
| Net Income | -48.34M |
| EBITDA | -57.80M |
| EBIT | -57.85M |
| Loss Per Share | -$0.81 |
Full Income StatementBalance Sheet
The company has $51.11 million in cash and $759,434 in debt, giving a net cash position of $50.35 million or $0.74 per share.
| Cash & Cash Equivalents | 51.11M |
| Total Debt | 759,434 |
| Net Cash | 50.35M |
| Net Cash Per Share | $0.74 |
| Equity (Book Value) | 76.16M |
| Book Value Per Share | 1.20 |
| Working Capital | 75.02M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$51.56 million and capital expenditures -$44,583, giving a free cash flow of -$52.95 million.
| Operating Cash Flow | -51.56M |
| Capital Expenditures | -44,583 |
| Free Cash Flow | -52.95M |
| FCF Per Share | -$0.78 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -41,252.05% |
| Pretax Margin | -34,462.68% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |